Sign In
Buy TBPMF
$0.0009
+0 (+0%)
At Close: Dec 14, 2023
Tetra Bio-Pharma to monetize Dronabinol and Botanical product portfolios
08:58am, Thursday, 25'th Feb 2021
Tetra Bio-Pharma Inc (TSX:TBP) (OTCQB:TBPMF) (FRA:JAM1) said it has signed a letter of intent (LOI) with Danish company DanCann Pharma for the exclusive distribution of its Reduvo Adversa and QIXLEEF
Tetra Bio-Pharma upsizes 'bought-deal' equity unit purchase agreement for gross proceeds of $12,540,000
11:00am, Tuesday, 23'rd Feb 2021
Tetra Bio-Pharma Inc. (TSX:TBP) said Tuesday that it has upsized the 'bought-deal' offering it announced late on Monday to an aggregate of 57,000,000 equity units of the company at an unchanged pric
Tetra Bio-Pharma inks 'bought-deal' equity unit purchase agreement for gross proceeds of $10,010,000
10:17am, Tuesday, 23'rd Feb 2021
Tetra Bio-Pharma Inc. (TSX:TBP) said late on Monday that it has entered into an agreement with Canaccord Genuity and Leede Jones Gable under which they will as underwriters purchase, on a bought-de
Tetra Bio-Pharma CEO details plans to advance coronavirus and cancer pain treatments through to commercialization
07:59am, Tuesday, 09'th Feb 2021
Tetra Bio-Pharma (TSE:TBP) (OTCMKTS:TBPMF) is off to a fantastic start to the year. Both Bay Street and Wall Street are firmly focused on the biotechnology company's pipeline of cannabinoid-based drug
Tetra Bio-Pharma Files New Drug Submission for REDUVO(TM) in Canada
06:30am, Wednesday, 30'th Dec 2020
The addressable market is estimated to be $80M CDN by 2022 Tetra meets another key milestone before the end of the year OTTAWA, ON / ACCESSWIRE / December 30, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or
Tetra Bio-Pharma Confirms it is on Track to Receive Government Funding
06:30am, Monday, 21'st Dec 2020
Tetra Provides Update on ARDS-003 Tetra Eyes Global Sepsis Market OTTAWA, ON / ACCESSWIRE / December 21, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF), a leader in can
